121 related articles for article (PubMed ID: 32723624)
1. Characterization of inflammatory bowel disease in Colombia: Results of a national register.
Juliao-Baños F; Puentes F; López R; Saffon MA; Reyes G; Parra V; Galiano MT; Barraza M; Molano J; Álvarez E; Corrales R; Vargas LE; Gil F; Álvarez P; Limas L; Prieto R; Yance P; Díaz F; Bareño J; ;
Rev Gastroenterol Mex (Engl Ed); 2021; 86(2):153-162. PubMed ID: 32723624
[TBL] [Abstract][Full Text] [Related]
2. Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia.
Parra-Izquierdo V; Flórez Sarmiento C; Frías-Ordoñez JS; Vargas M; Kock J; Lozano Escobar N; Márquez JR
Gastroenterol Hepatol; 2023 Oct; 46(8):585-593. PubMed ID: 36464080
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study.
Balderramo D; Yamamoto-Furusho J; Ponce de León E; de María J; Zubiaurre I; Pedreira S; Lis C; Brion L; de Paula JA
Gastroenterol Hepatol; 2024 Jan; 47(1):51-62. PubMed ID: 37062500
[TBL] [Abstract][Full Text] [Related]
4. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
[TBL] [Abstract][Full Text] [Related]
5. [Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014].
Guan DX; Yu FH; Wang GL; Zhou J; Wang DY; Nie XL; Xu XW
Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):493-498. PubMed ID: 28728256
[No Abstract] [Full Text] [Related]
6. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
7. Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease-EXVEDOCOL.
Parra V; Cifuentes S; Avendaño S; Ponce de León E; Florez C; Reyes G; Puentes F; Ballesteros M; Nuñez E; Gómez F; Márquez JR
Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38311006
[TBL] [Abstract][Full Text] [Related]
8. Biological therapy, surgery, and hospitalization rates for inflammatory bowel disease: An observational Latin American comparative study between adults and pediatric patients.
Silva ACV; Tumelero TJ; Yamamoto DR; Truppel SK; da Silva GS; Ribeiro LBM; Zacharias P; Olandoski M; Magro DO; Vieira MC; Kotze PG
Gastroenterol Hepatol; 2023 Oct; ():. PubMed ID: 37890582
[TBL] [Abstract][Full Text] [Related]
9. Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior.
Banerjee R; Pal P; Hutfless S; Ganesh BG; Reddy DN
Intest Res; 2019 Oct; 17(4):486-495. PubMed ID: 31370386
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
11. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
Kristensen MS; Kjærulff TM; Ersbøll AK; Green A; Hallas J; Thygesen LC
Inflamm Bowel Dis; 2019 Apr; 25(5):886-893. PubMed ID: 30551218
[TBL] [Abstract][Full Text] [Related]
14. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
15. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
16. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
[TBL] [Abstract][Full Text] [Related]
17. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES.
Quaresma AB; Coy CSR; Damião AOMC; Kaplan GG; Kotze PG
Arq Gastroenterol; 2019; 56(3):318-322. PubMed ID: 31633732
[TBL] [Abstract][Full Text] [Related]
18. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies.
Rozich JJ; Dulai PS; Fumery M; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2437-2447.e6. PubMed ID: 32142940
[TBL] [Abstract][Full Text] [Related]
19. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
20. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
